Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.22% |
| 2 | Technology | 4.92% |
| 3 | Industrials | 4.28% |
| 4 | Consumer Discretionary | 4.13% |
| 5 | Healthcare | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
2601
DELISTED
Meridian Bioscience Inc
VIVO
| $5.14M | ﹤0.01% |
323,315
+271,472
| +524% | +$4.05M |
|
2602
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
| $5.13M | ﹤0.01% |
+78,596
| New | +$5.52M |
|
2603
Pitney Bowes
PBI
$2.25B
| $5.13M | ﹤0.01% |
598,373
-1,235,618
| -67% | -$11.9M |
|
2604
Qorvo
QRVO
$8.66B
| $5.13M | ﹤0.01% |
63,925
+24,994
| +64% | +$1.93M |
|
2605
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$249M
| $5.12M | ﹤0.01% |
+255,716
| New | +$5.4M |
|
|
PRFT
2606
DELISTED
Perficient Inc
PRFT
| $5.12M | ﹤0.01% |
194,140
+50,116
| +35% | +$1.26M |
|
2607
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$167M
| $5.11M | ﹤0.01% |
56,241
+17,584
| +45% | +$1.95M |
|
2608
Larimar Therapeutics
LRMR
$453M
| $5.11M | ﹤0.01% |
41,637
+15,379
| +59% | +$1.31M |
|
2609
Sociedad Química y Minera de Chile
SQM
$21.2B
| $5.11M | ﹤0.01% |
106,273
+35,932
| +51% | +$1.88M |
|
2610
PUT
Aon
AON
$75.5B
| $5.1M | ﹤0.01% |
37,200
+9,800
| +36% | +$1.38M |
|
|
ECHO
2611
DELISTED
Echo Global Logistics, Inc.
ECHO
| $5.1M | ﹤0.01% |
174,349
+44,588
| +34% | +$1.27M |
|
2612
PUT
3D Systems Corp
DDD
$616M
| $5.1M | ﹤0.01% |
369,100
+75,600
| +26% | +$937K |
|
2613
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.39B
| $5.09M | ﹤0.01% |
382,000
-193,000
| -34% | -$2.51M |
|
2614
CALL
PACCAR
PCAR
$68.8B
| $5.09M | ﹤0.01% |
123,150
-4,650
| -4% | -$201K |
|
2615
CALL
Murphy Oil
MUR
$4.96B
| $5.08M | ﹤0.01% |
150,400
+88,400
| +143% | +$2.73M |
|
2616
Orthofix Medical
OFIX
$421M
| $5.08M | ﹤0.01% |
89,393
+63,273
| +242% | +$3.6M |
|
2617
Anika Therapeutics
ANIK
$288M
| $5.07M | ﹤0.01% |
158,509
+111,664
| +238% | +$4.6M |
|
2618
KB Home
KBH
$3.44B
| $5.07M | ﹤0.01% |
186,199
-43,649
| -19% | -$1.17M |
|
|
ZAYO
2619
CALL
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $5.07M | ﹤0.01% |
139,000
+59,600
| +75% | +$2.12M |
|
2620
CALL
AerCap
AER
$24B
| $5.07M | ﹤0.01% |
93,600
+11,700
| +14% | +$630K |
|
|
ICPT
2621
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.06M | ﹤0.01% |
60,300
-500
| -0.8% | -$36.6K |
|
2622
Thomson Reuters
TRI
$44.9B
| $5.06M | ﹤0.01% |
108,022
-4,422
| -4% | -$203K |
|
2623
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
| $5.06M | ﹤0.01% |
180,600
+51,000
| +39% | +$1.56M |
|
2624
CALL
Rockwell Automation
ROK
$49.9B
| $5.05M | ﹤0.01% |
30,400
+4,600
| +18% | +$799K |
|
2625
CALL
Reliance Steel & Aluminium
RS
$21.8B
| $5.05M | ﹤0.01% |
57,700
+7,900
| +16% | +$718K |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,571 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,571 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.